Main Menu
Menu

Lamar Smith

Publish Date
Op-Eds
People are fed up, and Trump needs affordability win. Here’s his chance
The Washington Examiner
News
Senate Finance Committee Hears from ITC Nominees
IPWatchdog
Resources
Letters
C4IP Letter to Senate Finance Committee RE: Nomination of Peter-Anthony Pappas to the U.S. International Trade Commission
BlogFact Checks
Fact Check: Setting the Record Straight on PTAB Reform

The U.S. Patent and Trademark Office is considering reforms to address longstanding concerns about abuse of the Patent Trial and Appeal Board...

News
Senate Finance Committee to Hold Nomination Hearing on Pappas’ USITC Appointment
IPWatchdog
Press Releases
Council for Innovation Promotion Applauds Senate Judiciary Committee Advancement of the NO FAKES Act

WASHINGTON (June 18, 2026) — Today, the Senate Judiciary Committee voted to advance the bipartisan Nurture Originals, Foster Art, and Keep Entertainment...

Op-Eds
Intellectual property supports the U.S. economy. It should be respected abroad.
The Washington Post
Press Releases
Council for Innovation Promotion Urges Senate Judiciary Committee To Advance NO FAKES Act

WASHINGTON (June 16, 2026) — On June 18, the Senate Judiciary Committee will vote on whether to advance the bipartisan Nurture Originals,...

Resources
Letters
C4IP Letter to Senate HELP Committee RE: Consideration of Medication Affordability and Patent Integrity Act
Blog
Inventor Spotlight: Robert Goddard

C4IP is recognizing Robert Goddard (1882-1945), the “Father of American Rocketry,” whose numerous patented inventions enabled modern spaceflight. Goddard was born amid...

News
C4IP Opposes Prohibiting Adversarial Patents Act, Releases Technology Ecosystems Report
IPWatchdog
News
Prohibiting Adversarial Patents Act Would Limit Patent Rights of National Security-Designated Entities
IPWatchdog
News:

News:

PERA 2025 Debated in Senate IP Subcommittee Hearing, with Business Methods, Diagnostics in Focus,

10/08/2025
News:

News:

US Senate continues uphill battle on patent eligibility bill,

10/07/2025
Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing,

10/07/2025
Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025
News:

News:

How impactful is the new USPTO director’s S101 decision?,

10/02/2025
Blog:

Blog:

Inventor Spotlight: John B. Goodenough,

09/26/2025
Blog:

Blog:

Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA),

09/25/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025
News:

News:

Amgen Attacks Academics’ False Claims About Biologic Patents,

09/21/2025
News:

News:

C4IP Publishes Website Addressing Misinformation Published by I-MAK,

09/19/2025
Blog:

Blog, Fact Checks:

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry,

09/19/2025
Scroll to Top